Richard Bagley

2012

In 2012, Richard Bagley earned a total compensation of $716K as President, Chief Operating Officer and Chief Financial Officer at ZIOPHARM Oncology, a 10% increase compared to previous year.

Compensation breakdown

Salary$206,329
Other$509,644
Total$715,973

Bagley received $509.6K in other compensation, accounting for 71% of the total pay in 2012.

Bagley also received $206.3K in salary.

Rankings

In 2012, Richard Bagley's compensation ranked 7,479th out of 11,487 executives tracked by ExecPay. In other words, Bagley earned more than 34.9% of executives.

ClassificationRankingPercentile
All
7,479
out of 11,487
35th
Division
Manufacturing
2,691
out of 4,253
37th
Major group
Chemicals And Allied Products
694
out of 1,198
42nd
Industry group
Drugs
483
out of 920
48th
Industry
Pharmaceutical Preparations
381
out of 700
46th
Source: SEC filing on April 29, 2013.

Bagley's colleagues

We found four more compensation records of executives who worked with Richard Bagley at ZIOPHARM Oncology in 2012.

2012

Jonathan Lewis

ZIOPHARM Oncology

Chief Executive Officer

2012

Jason Amello

ZIOPHARM Oncology

Chief Financial Officer

2012

Hagop Youssoufian

ZIOPHARM Oncology

Chief Medical Officer

2012

Caesar Belbel

ZIOPHARM Oncology

Chief Legal Officer

You may also like